|
|
|
Volumn 23, Issue 5 SUPPL. 10, 1996, Pages 25-31
|
|
Phase I studies with the novel nucleoside analog gemcitabine
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOTRANSFERASE;
BILIRUBIN;
CREATININE;
CYTARABINE;
DEAMINASE;
DEOXYCYTIDINE;
DEOXYCYTIDINE KINASE;
DEOXYCYTIDINE TRIPHOSPHATE;
DNA;
FLOXURIDINE DERIVATIVE;
GEMCITABINE;
NUCLEOSIDE ANALOG;
ANTINEOPLASTIC ACTIVITY;
BONE MARROW SUPPRESSION;
CLINICAL TRIAL;
HUMAN;
HYPOTENSION;
INFLUENZA;
INTRAVENOUS DRUG ADMINISTRATION;
MALIGNANT NEOPLASTIC DISEASE;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
THROMBOCYTOPENIA;
ANTIMETABOLITES, ANTINEOPLASTIC;
CLINICAL TRIALS, PHASE I;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
NEOPLASMS;
|
|
EID: 0029852961
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (48)
|
|
References (0)
|
